Get the Stockscreener App
3.05
2.56%
-0.08
After Hours:
2.88
-0.17
-5.57%
Onconetix Inc stock is traded at $3.05, with a volume of 25,082.
It is down -2.56% in the last 24 hours and up +3.04% over the past month.
Onconetix Inc is a commercial-stage biotechnology company focused on the research, development, and commercialization of solutions for men's health and oncology. It has a product named Entadfi an FDA-approved once-daily oral therapeutic for the treatment of benign prostatic hyperplasia, a disorder of the prostate, along with building additional assets in therapeutics, diagnostics, and clinician services for oncology.
See More
Previous Close:
$3.13
Open:
$3.05
24h Volume:
25,082
Relative Volume:
0.04
Market Cap:
$4.71M
Revenue:
-
Net Income/Loss:
$-53.12M
P/E Ratio:
-0.028
EPS:
-108.8
Net Cash Flow:
$-15.86M
1W Performance:
+9.71%
1M Performance:
+3.04%
6M Performance:
-79.02%
1Y Performance:
-99.32%
1-Day Range:
$3.0282
$3.12
1-Week Range:
$2.64
$3.17
52-Week Range:
$2.61
$552.50
Onconetix Inc Stock (ONCO) Company Profile
Name
Onconetix Inc
Sector
Industry
Phone
513-620-4101
Address
201 E. FIFTH STREET, CINCINNATI
Compare ONCO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ONCO
Onconetix Inc
|
3.05 | 4.25M | 0 | -53.12M | -15.86M | -108.80 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Onconetix Inc Stock (ONCO) Latest News
Is this a good reentry point in Onconetix Inc.Market Weekly Review & Verified Entry Point Signals - Newser
Analyzing recovery setups for Onconetix Inc. investorsMarket Activity Report & AI Forecast for Swing Trade Picks - Newser
Onconetix Inc. stock daily chart insightsGold Moves & Free Safe Capital Growth Stock Tips - Newser
Detecting support and resistance levels for Onconetix Inc.Earnings Beat & Weekly High Potential Stock Alerts - Newser
Using economic indicators to assess Onconetix Inc. potentialQuarterly Portfolio Report & Real-Time Market Sentiment Reports - Newser
What high frequency data says about Onconetix Inc.2025 Earnings Surprises & Low Risk Entry Point Guides - Newser
What to expect from Onconetix Inc. in the next 30 daysQuarterly Profit Summary & Daily Volume Surge Signals - Newser
What does recent volatility data suggest for Onconetix Inc.Portfolio Update Report & Growth Oriented Trade Recommendations - Newser
Is now a turning point for Onconetix Inc.July 2025 Sector Moves & Real-Time Chart Pattern Alerts - Newser
Is Onconetix Inc. stock ready for a breakout2025 Historical Comparison & AI Based Buy and Sell Signals - Newser
Real time scanner hits for Onconetix Inc. explainedWall Street Watch & Long-Term Capital Growth Ideas - Newser
Quantitative breakdown of Onconetix Inc. recent moveQuarterly Profit Review & Accurate Buy Signal Alerts - Newser
What moving averages say about Onconetix Inc.Trade Analysis Summary & Daily Oversold Stock Bounce Ideas - Newser
Onconetix Issues Promissory Notes to Keystone Capital - MSN
Is Onconetix Inc. forming a reversal patternMarket Activity Report & Low Risk Growth Stock Ideas - Newser
Trend analysis for Onconetix Inc. this weekRecession Risk & Precise Buy Zone Tips - Newser
How to escape a deep drawdown in Onconetix Inc.July 2025 Momentum & Low Risk Investment Opportunities - Newser
Building trade automation scripts for Onconetix Inc.Price Action & Low Drawdown Momentum Ideas - Newser
Has Onconetix Inc. found a price floorMarket Performance Report & Reliable Breakout Forecasts - Newser
Using R and stats models for Onconetix Inc. forecastingEntry Point & AI Powered Market Entry Ideas - Newser
Published on: 2025-09-08 15:42:16 - Newser
Regression analysis insights on Onconetix Inc. performanceEarnings Miss & AI Driven Stock Price Forecasts - Newser
Full technical analysis of Onconetix Inc. stockEarnings Overview Summary & Low Drawdown Momentum Trade Ideas - Newser
What’s the analyst consensus on Onconetix Inc.2025 Fundamental Recap & Safe Entry Point Identification - 뉴스영
Onconetix Inc. stock trend forecastJuly 2025 Opening Moves & Consistent Income Trade Ideas - Newser
Onconetix Inc Stock (ONCO) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):